Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
5650studies shown
Showing 4,093-4,104 of 5,650
Other study type icon
RecruitingISRCTN69583343

Provision for parents on psychiatric inpatient units

This observational study is following people with Experience of treatment within a psychiatric inpatient unit or Mental and Behavioural Disorders to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.

In United Kingdom
Mental healthOtherFrom 8 Years to 100 Years
Countries
United Kingdom
Sponsor
University of Sussex
Condition
Mental health
Other study type icon
RecruitingISRCTN21715876

Provision of mental health treatment in general practice settings: outcome and cost effectiveness analysis

This study is looking at care and outcomes for people with Mental and behavioural disorders: schizophrenia and other psychoses, depression, anxiety, neuroses, Mental and Behavioural Disorders, or Schizophrenia. Taking part may give some people access to 1, but direct benefit is not guaranteed.

In United Kingdom
Schizophrenia, Depression, ...Other
Countries
United Kingdom
Sponsor
NHS R&D Regional Programme Register - Department of Health (UK)
Condition
Schizophrenia, Depression, ...
Other study type icon
RecruitingISRCTN61088114

Provision Of Psychological support to People in Intensive care (POPPI): feasibility study

This study is looking at whether The intervention to be assessed is a complex psychological intervention comprising four related elements: 1 can help people with Topic: Critical Care, Mental Health, Subtopic: Critical Care, Anxiety, Disease: All Critical care, Anxiety, or Mental and Behavioural Disorders. Participants take part in The intervention to be assessed is a complex psychological intervention comprising four related elements: 1 and complete follow-up assessments.

In United Kingdom
AnxietyOtherOver 18 Years
Countries
United Kingdom
Sponsor
Intensive Care National Audit & Research Centre (UK)
Condition
Anxiety
Other study type icon
RecruitingISRCTN53448131

Provision of psychological support to people in intensive care (v1.0)

This study is looking at whether 1 can help people with Topic: Mental Health, Critical care, Subtopic: Anxiety, Critical care, Disease: Anxiety, All Critical care, or Mental and Behavioural Disorders. Participants take part in 1 and complete follow-up assessments.

In United Kingdom
AnxietyOtherOver 18 Years
Countries
United Kingdom
Sponsor
Intensive Care National Audit & Research Centre
Condition
Anxiety
Device study icon
RecruitingNCT06400810

Proximal Risk for Suicide in Adolescents

This summary needs review. Please check the official study record and contact the research team for details.

In Portland
SuicidalityDeviceA study involving a tool, app, wearable, test, or medical device.From 13 Years to 17 Years
Countries
United States
Sponsor
Oregon Health and Science University
Condition
Suicidality
Drug study icon
RecruitingNCT06898606

Psilocybe Cubensis Mushrooms With or Without Fluoxetine for Refractory Depression

This study is comparing Psilocybin and Psilocyn with placebo for people with depression. Participants receive Psilocybin and Psilocyn or placebo and complete study visits and assessments.

In Foz do Iguaçu
DepressionDrugA study involving a medication or substance.From 25 Years to 65 Years
Countries
Brazil
Sponsor
Federal University of Latin American Integration
Condition
Depression
Drug study icon
RecruitingISRCTN10441504

Psilocybin as a treatment for Eating disorders

This summary needs review. Please check the official study record and contact the research team for details.

In United Kingdom
Eating disordersOther
Countries
United Kingdom
Sponsor
Imperial College London
Condition
Eating disorders
Drug study icon
RecruitingNCT06796062

Psilocybin for Addiction (OUD)

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Albuquerque
AddictionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
NYU Langone Health
Condition
Addiction
Drug study icon
RecruitingISRCTN14426797

Psilocybin for depression

This study is looking at whether Two doses of psilocybin 10mg and 25mg per so, separated by one week can help people with Major depression, Mental and Behavioural Disorders, or Depression. Participants receive a study treatment and complete follow-up visits and assessments.

In United Kingdom
DepressionOther
Countries
United Kingdom
Sponsor
Imperial College London
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.